Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 19, 2025 04:06 ET | Source: Research and Markets

Focal Segmental Glomerulosclerosis Pipeline & Market Insights Report 2025 Featuring Emerging Drugs Sparsentan (Travere Therapeutics), DMX-200 (Dimerix Bioscience), and WAL0921 (Walden Biosciences)

Dublin, Aug. 19, 2025 (GLOBE NEWSWIRE) -- The "Focal Segmental Glomerulosclerosis - Pipeline Insight, 2025" has been added to ResearchAndMarkets.com's offering. This report offers a detailed...